Revenue trajectory remains highly unstable following the iCoreConnect merger, with quarterly SG&A expenses peaking at $9.9 million in 2023Q4, significantly outpacing the $2.8 million revenue reported in 2024Q3.
| Net Interest Income | 722.22K | 3.04M | 0 | 0 | 0 | 0 |
| NII Growth % | 0% | - | - | - | - | - |
| Net Interest Margin % | 0.87% | 3.67% | 0% | 0% | 0% | - |
| Interest Income | 722.22K | 3.04M | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | -1.11M | 0 | 0 |
| Loan Loss Provision | 0 | 0 | 2.5M | 3.14M | 0 | 0 |
| Non-Interest Income | -722.22K | -3.04M | 10.75M | 8.15M | 0 | 0 |
| Non-Interest Income % | - | - | 100% | 100% | - | - |
| Total Revenue | 0 | 0 | 10.75M | 8.15M | 0 | 0 |
| Revenue Growth % | -200% | -100% | 31.83% | - | - | - |
| Non-Interest Expense | 483.96K | 972.16K | 21.26M | 15.12M | 1.09M | 1.8K |
| Efficiency Ratio | - | - | 197.84% | 185.54% | - | - |
| Operating Income | -483.96K | -972.16K | -15.51M | -10.28M | -1.09M | -1.8K |
| Operating Margin % | - | - | -144.3% | -126.07% | - | - |
| Operating Income Growth % | - | 93.73% | -50.89% | -840.34% | -60547.17% | - |
| Pretax Income | 1.64M | 2.06M | -33.2M | -15.92M | 89.21K | -1.8K |
| Pretax Margin % | - | - | -308.95% | -195.3% | - | - |
| Income Tax | 455.64K | 637.75K | 0 | 0 | 215K | 0 |
| Effective Tax Rate % | 27.77% | 30.89% | 0% | 0% | 241% | 0% |
| Net Income | 1.18M | 1.43M | -25.85K | -15.92M | -125.79K | -1.8K |
| Net Margin % | - | - | -0.24% | -195.3% | - | - |
| Net Income Growth % | 105% | 5620.23% | 99.84% | -12556.4% | -6880.52% | - |
| Net Income (Continuing) | 1.18M | 1.43M | -25.85K | -15.92M | -125.79K | -1.8K |
| EPS (Diluted) | 0.13 | 0.14 | -0.00 | -2.17 | -0.01 | -0.00 |
| EPS Growth % | 104.5% | - | 99.89% | -15074.83% | - | - |
| EPS (Basic) | - | 0.15 | -0.00 | -2.17 | -0.01 | -0.00 |
| Diluted Shares Outstanding | 8.8M | 8.08M | 10.9M | 7.35M | 8.79M | 4.59M |
Post-merger integration execution
As reported in financial statements, FGMC's revenue trajectory shifted from zero during its shell phase to $2.8 million in 2024Q3, reflecting the inherent instability of a newly combined entity transitioning from a SPAC vehicle into an active healthcare communications provider after the iCoreConnect merger.
The sudden appearance of revenue followed by the cessation of shell-phase reporting suggests that historical growth metrics are largely irrelevant for forecasting future performance. Investors should monitor whether the company can establish a consistent, recurring revenue base now that it has moved beyond the binary search-and-acquire phase.
Based on reported figures, the company's SG&A expenses fluctuated significantly, peaking at $9.9 million in 2023Q4, which highlights the substantial professional and legal costs required to navigate the complex regulatory environment associated with finalizing a business combination in the financial services and healthcare sectors.
The high overhead relative to the nascent revenue stream indicates that the company is currently operating with a cost structure designed for deal-making rather than efficient service delivery. Future profitability will depend heavily on management's ability to rationalize these legacy transaction-related expenses and pivot toward a scalable operating model.
According to recent SEC filings, the company recorded $6.0 million in stock-based compensation during 2024Q3, a significant non-cash expense that complicates the interpretation of net income and suggests that equity-based incentives are playing a major role in the compensation structure of the newly formed entity.
The presence of such substantial non-cash charges warrants further investigation into the dilution risks for public shareholders. Analysts should be cautious when evaluating net income, as these items may mask the underlying cash-burn reality of the business during its initial post-merger integration period.
As indicated by the high redemption levels during the merger vote, the company's cash position appears strained, potentially limiting the capital available for the growth initiatives required to compete effectively in the healthcare SaaS market against established industry peers like Butterfly Network.
The potential for a liquidity shortfall may force the company to seek dilutive secondary financing sooner than anticipated, which could undermine the value proposition for existing shareholders. Investors should monitor the cash runway closely, as the current balance may be insufficient to support long-term operational scaling without further capital raises.
Quick answers to the most common questions about buying FGMC stock.
FG Merger Corp. (FGMC) is profitable, generating $1.4M in net income for the fiscal year ending 2025.